Commentary · 1 Jul 2026
Conference abstractPublished 26 Oct 2016
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas
Bari "Aldo Moro" University School of Medicine, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There are contrasting views on whether familial non medullary thyroid carcinomas (FNMTCs) are characterÃ?¬ized by aggressive behavior and limited evidence exists on the prognostic value of BRAF and RAS mutations in these tumors. Thus, in the present study, clinic pathological features were analyzed in 386 non medullary thyroid carcinomas (NMTCs), subdivided in 82 familial and 304 sporadic cases. Furthermore, the RAS and BRAF mutational statuses were investigated in a subgroup of 34 FNMTCs to address their clinical and biologÃ?¬ical significance. The results demonstrated that, compared with sporadic NMTCs, FNMTCs are characterized by significantly higher rates of multi-centricity and bi-laterality and are more frequently associated with chronic autoimmune thyroiditis. Notably, a statistically significant difference in the rates of multi-centricity was observed by sub-grouping familial tumors according to the number of relatives involved; those with âÂ?¥3 affected relatives were more likely to be multi-centric. FurtherÃ?¬more, the FNMTC cohort exhibited higher rates of tumors >4 cm in size with extra-thyroidal or lymph node involvement. However, no significant difference was observed. Similarly, no differences were observed with respect to the age of onset or the patient outcome. The mutational profiling exhibited a rate of 58.8% for BRAF V600E mutations in familial tumors, which is at the upper limit of the mutational frequency observed in historical series of sporadic thyroid cancer. A high rate of NRAS mutations (17.6%) was also observed, mostly in the follicular variant histo-type. Notably, compared with BRAF/RAS wild-type FNMTCs, the familial carcinomas bearing BRAF NRAS mutations exhibited slightly higher rates of bi-laterality and multi-centricity, in addition to increased frequency of locally advanced stage or lymph node involveÃ?¬ment. The present data support the theory that FNMTCs are characterized by clinic-pathological features that resemble a more aggressive phenotype and suggest that RAS/BRAF mutaÃ?¬tional analysis deserves to be further evaluated as a tool for the identification of FNMTCs with a potentially unfavorable prognosis.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Anna Ciampolillo”
